<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(2)</volume><submitter>Liu Q</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast cancer has become a severe threat to human health, making it imperative to identify effective drugs and therapeutic targets.&lt;h4>Methods&lt;/h4>Various molecular biology experiments, such as western blot analysis, cytologic effect, co-immunoprecipitation, and immunofluorescence assays, as well as a nude mouse xenograft tumor model, were used to comprehensively analyze the impact of gamma-interferon-inducible lysosomal thiol reductase (GILT) on the malignant phenotype of breast cancer cells. This work was performed to examine GILT expression levels and explore the potential mechanism in breast cancer.&lt;h4>Results&lt;/h4>GILT protein expression levels were significantly lower in breast cancer cells than in normal breast epithelial cells. Overexpressing GILT inhibited breast</pubmed_abstract><journal>Cancer innovation</journal><pagination>e161</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11909800</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell Proliferation.</pubmed_title><pmcid>PMC11909800</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Shao Y</pubmed_authors><pubmed_authors>Guan X</pubmed_authors><pubmed_authors>Feng K</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Yuan X</pubmed_authors><pubmed_authors>Chu M</pubmed_authors><pubmed_authors>Wei L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell Proliferation.</name><description>&lt;h4>Background&lt;/h4>Breast cancer has become a severe threat to human health, making it imperative to identify effective drugs and therapeutic targets.&lt;h4>Methods&lt;/h4>Various molecular biology experiments, such as western blot analysis, cytologic effect, co-immunoprecipitation, and immunofluorescence assays, as well as a nude mouse xenograft tumor model, were used to comprehensively analyze the impact of gamma-interferon-inducible lysosomal thiol reductase (GILT) on the malignant phenotype of breast cancer cells. This work was performed to examine GILT expression levels and explore the potential mechanism in breast cancer.&lt;h4>Results&lt;/h4>GILT protein expression levels were significantly lower in breast cancer cells than in normal breast epithelial cells. Overexpressing GILT inhibited breast</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-04-22T07:27:38.677Z</modification><creation>2025-04-05T22:08:26.174Z</creation></dates><accession>S-EPMC11909800</accession><cross_references><pubmed>40094073</pubmed><doi>10.1002/cai2.161</doi></cross_references></HashMap>